You are here

MEDICAL ARTICLES

To explain a person's actions in the present, it sometimes helps to understand their past, including where they come from and how they were raised. This is also true of tumors. Delving into a tumor's cellular lineage, a Ludwig Cancer Research study shows, can reveal weaknesses to target for customized therapies.

The findings, detailed in the April 24 issue of the journal Nature, also illustrate how knowledge of the biochemistry and microenvironment of the tissue from which a tumor arises can help predict the genetic alterations its cancer cells are likely to undergo.

Case Western Reserve University researchers and partners, including a collaborator at Cleveland Clinic, are pushing the boundaries of how "smart" diagnostic-imaging machines identify cancers--and uncovering clues outside the tumor to tell whether a patient will respond well to chemotherapy.

Scientists at the UNC School of Medicine have revealed that the reason we eat more than we need to may be caused by cellular communication originating in the emotion-processing center of the brain. The research was published in the journal Neuron yesterday.

Restrictive prior authorization practices cause unnecessary delays and interference in care decisions for cancer patients, according to a new survey of nearly 700 radiation oncologists -- physicians who treat cancer patients using radiation-- released today by the American Society for Radiation Oncology (ASTRO).

Tags: Diabetes, Spectroscopy31/03/2019

Diabetes, also known as diabetes mellitus, is a chronic metabolic disorder that affects roughly 8.5% of the world’s population, i.e., over 420 million people. In the last three decades or so, rates of diabetes have almost doubled which can be attributed to adoption of western eating habits and increased urbanization in many developing countries.

Tags: Blood, Glucose, test31/03/2019

Blood glucose control is required to be performed frequently and accurately, as well as safely, in many clinical situations. This helps diabetics to monitor their glucose levels without having to visit the doctor’s office or hospital, and thus makes stabilization of blood sugar achievable on a larger scale.

In many cases, it is preferable for the testing to be carried out at home, because it is less expensive, less invasive, and safer.

New research demonstrating the clinical utility of Bio-Rad's Droplet Digital PCR (ddPCR) powered liquid biopsy will be presented this week during the 2019 American Association for Cancer Research (AACR) Annual Meeting in Atlanta, March 29-April 3. Many of the studies rely on the sensitivity, speed, and cost-effectiveness of ddPCR technology to measure blood-based tumor biomarkers in a reproducible way.

Pages